Copper-64 (T_1/2 = 12.7 h) is a positron and beta-emitting isotope, with decay characteristics suitable for both positron emission tomography (PET) imaging and radiotherapy of cancer. Copper-67 (T_1/2 = 61.8 h) is a beta and gamma emitter, appropriate for radiotherapy β-energy and with a half-life suitable for single-photon emission computed tomography (SPECT) imaging. The chemical identities of ⁶⁴Cu and ⁶⁷Cu isotopes allow for convenient use of the same chelating molecules for sequential PET imaging and radiotherapy. A recent breakthrough in ⁶⁷Cu production opened previously unavailable opportunities for a reliable source of ⁶⁷Cu with high specific activity and purity. These new opportunities have reignited interest in the use of copper-containing radiopharmaceuticals for the therapy, diagnosis, and theranostics of various diseases. Herein, we summarize recent (2018–2023) advances in the use of copper-based radiopharmaceuticals for PET, SPECT imaging, radiotherapy, and radioimmunotherapy.

The results of experimentally and theoretically studying the photodisintegration of molybdenum isotopes are presented. The yields of various photonucleon reactions on stable molybdenum isotopes were determined by the gamma-activation method. Use was made of bremsstrahlung photons from an electron accelerator that were characterized by the endpoint energies of 19.5, 29.1, and 67.7 MeV. Reactions involving the emission of up to three nucleons from the target nucleus were observed. The experimental results in question were compared with theoretical predictions based on the combined photonucleon-reaction model and obtained for 15 molybdenum isotopes. The relations between basic photonucleon reactions on the molybdenum isotopes considered in our present study were explained.

²³⁸U photofission is studied in the region of nuclear excitation energies that extends up to 20 MeV. Independent photofission-fragment yields and cumulative photofission-fragment yields after the emission of fast neutrons are measured by gamma-spectroscopy methods. The mass distributions of photofission fragments are obtained at the endpoint bremsstrahlung energies of 19.5, 29.1, 48.3, and 67.7 MeV. A comparative analysis of the behavior of the symmetric and asymmetric modes of photoninduced fission as a function of the average excitation energy of the fissioning nucleus is performed. The integrated yield of ²³⁸U photofission is calculated, and the evaluated cross sections for photofission and for photoneutron reactions are discussed.

Photofission of ²³⁸ U by bremsstrahlung photons is studied at four energies of an electron accelerator: 19.5, 29.1, 48.3, and 67.7 MeV. The yields of the fission fragments after the emission of prompt neutrons are obtained using the gamma-ray spectroscopic technique. The mass distributions of photofission are obtained at different upper energies of the bremsstrahlung spectrum. The ratio the symmetric-fission mode to the asymmetric mode is obtained from the mass distribution. The symmetric mode becomes 3–4 times greater than the asymmetric as the excitation energy of the ²³⁸U nucleus increases from 12 to 16 MeV.

In our work, the photonuclear production of ^198,199Au isotopes for nuclear medicine purposes was studied, and a method for their recovery from irradiated mercury was developed. The yields of the corresponding nuclear reactions were determined, and a comparison of various methods of obtaining gold radioisotopes was provided. New sorbents based on benzo-15-crown-5, which selectively binds gold, were studied, and the optimal conditions for Au recovery with a high degree of purification from mercury were found. It was established that, for the fast and quantitative recovery of Au isotopes, it was necessary to add at least 0.1 mg of the carrier. As a result, the developed method can be regularly used to obtain ^198,199Au for the research of radiopharmaceuticals based on them.